159 related articles for article (PubMed ID: 38739169)
1. Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment.
Zhang P; Wan Y; Ma J; Gong J; Zhong Z; Cui Y; Zhang H; Da Y; Ma J; Li C; Liu L; Gong T; Tan Y; Zhang C
Cancer Immunol Immunother; 2024 May; 73(7):127. PubMed ID: 38739169
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma.
Xu X; Pan X; Fan Z; Xia J; Ren X
Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019
[TBL] [Abstract][Full Text] [Related]
3. Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
Hong SM; Lee YK; Park I; Kwon SM; Min S; Yoon G
J Biol Chem; 2019 May; 294(19):7810-7820. PubMed ID: 30923124
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib.
Zhang Y; Feng J; Mi Y; Fan W; Qin R; Mei Y; Jin G; Mao J; Zhang H
Drug Metab Dispos; 2024 May; 52(6):555-564. PubMed ID: 38565301
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
[TBL] [Abstract][Full Text] [Related]
7. Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects.
Kim JH; Kim EL; Lee YK; Park CB; Kim BW; Wang HJ; Yoon CH; Lee SJ; Yoon G
Exp Cell Res; 2011 May; 317(8):1108-18. PubMed ID: 21356207
[TBL] [Abstract][Full Text] [Related]
8. Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma: Strobe-Compliant Article.
Chen R; Zhou X; Yu Z; Liu J; Huang G
Medicine (Baltimore); 2015 Sep; 94(39):e1583. PubMed ID: 26426634
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
[TBL] [Abstract][Full Text] [Related]
10. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
11. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
14. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
15. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
[TBL] [Abstract][Full Text] [Related]
16. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
18. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma.
Yang Z; Feng J; Xiao L; Chen X; Yao Y; Li Y; Tang Y; Zhang S; Lu M; Qian Y; Wu H; Shi M
Hepatology; 2020 May; 71(5):1626-1642. PubMed ID: 31479523
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
